186 related articles for article (PubMed ID: 34800199)
1. Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease.
Májovská J; Hennig A; Nestrasil I; Schneider SA; Jahnová H; Vaněčková M; Magner M; Dušek P
Neurol Sci; 2022 May; 43(5):3273-3281. PubMed ID: 34800199
[TBL] [Abstract][Full Text] [Related]
2. Quantitative brain morphometry identifies cerebellar, cortical, and subcortical gray and white matter atrophy in late-onset Tay-Sachs disease.
Májovská J; Nestrašil I; Ahmed A; Bondy MT; Klempíř J; Jahnová H; Schneider SA; Horáková D; Krásenský J; Ješina P; Vaneckova M; Nascene DR; Whitley CB; Jarnes JR; Magner M; Dušek P
J Inherit Metab Dis; 2024 Mar; 47(2):327-339. PubMed ID: 38112342
[TBL] [Abstract][Full Text] [Related]
3. Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay-Sachs disease.
Jahnová H; Poupětová H; Jirečková J; Vlášková H; Košťálová E; Mazanec R; Zumrová A; Mečíř P; Mušová Z; Magner M
J Neurol; 2019 Aug; 266(8):1953-1959. PubMed ID: 31076878
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis.
Rowe OE; Rangaprakash D; Weerasekera A; Godbole N; Haxton E; James PF; Stephen CD; Barry RL; Eichler FS; Ratai EM
Mol Genet Metab; 2021 Aug; 133(4):386-396. PubMed ID: 34226107
[TBL] [Abstract][Full Text] [Related]
5. GM2 gangliosidosis variant B1 neuroradiological findings.
Grosso S; Farnetani MA; Berardi R; Margollicci M; Galluzzi P; Vivarelli R; Morgese G; Ballestri P
J Neurol; 2003 Jan; 250(1):17-21. PubMed ID: 12527987
[TBL] [Abstract][Full Text] [Related]
6. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
[TBL] [Abstract][Full Text] [Related]
7. Natural History of Adult Patients with GM2 Gangliosidosis.
Masingue M; Dufour L; Lenglet T; Saleille L; Goizet C; Ayrignac X; Ory-Magne F; Barth M; Lamari F; Mandia D; Caillaud C; Nadjar Y
Ann Neurol; 2020 Apr; 87(4):609-617. PubMed ID: 31995250
[TBL] [Abstract][Full Text] [Related]
8. Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients.
Neudorfer O; Pastores GM; Zeng BJ; Gianutsos J; Zaroff CM; Kolodny EH
Genet Med; 2005 Feb; 7(2):119-23. PubMed ID: 15714079
[TBL] [Abstract][Full Text] [Related]
9. Clinical and imaging predictors of late-onset GM2 gangliosidosis: A scoping review.
Godbole NP; Haxton E; Rowe OE; Locascio JJ; Schmahmann JD; Eichler FS; Ratai EM; Stephen CD
Ann Clin Transl Neurol; 2024 Jan; 11(1):207-224. PubMed ID: 38009419
[TBL] [Abstract][Full Text] [Related]
10. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.
Nestrasil I; Ahmed A; Utz JM; Rudser K; Whitley CB; Jarnes-Utz JR
Mol Genet Metab; 2018 Feb; 123(2):97-104. PubMed ID: 29352662
[TBL] [Abstract][Full Text] [Related]
11. Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset.
Kern J; Böhringer J; Timmann D; Trollmann R; Stendel C; Kamm C; Röbl M; Santhanakumaran V; Groeschel S; Beck-Wödl S; Göricke S; Krägeloh-Mann I; Synofzik M
Neurology; 2024 Jan; 102(1):e207898. PubMed ID: 38165373
[TBL] [Abstract][Full Text] [Related]
12. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system.
Miklyaeva EI; Dong W; Bureau A; Fattahie R; Xu Y; Su M; Fick GH; Huang JQ; Igdoura S; Hanai N; Gravel RA
Brain Res; 2004 Mar; 1001(1-2):37-50. PubMed ID: 14972652
[TBL] [Abstract][Full Text] [Related]
13. Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases.
Lyn N; Pulikottil-Jacob R; Rochmann C; Krupnick R; Gwaltney C; Stephens N; Kissell J; Cox GF; Fischer T; Hamed A
Orphanet J Rare Dis; 2020 Apr; 15(1):92. PubMed ID: 32295606
[TBL] [Abstract][Full Text] [Related]
14. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease.
Demir SA; Timur ZK; Ateş N; Martínez LA; Seyrantepe V
J Neuroinflammation; 2020 Sep; 17(1):277. PubMed ID: 32951593
[TBL] [Abstract][Full Text] [Related]
15. Late-onset Tay-Sachs disease presenting with a neuromuscular phenotype-a case series.
Fullam S; Togher Z; Power A; Kennelly L; McHugh JC; O'Dowd S; Tubridy N; Hardiman O; Costigan D; Ryan A; Lefter S; Connolly S; Murphy SM
Eur J Neurol; 2024 Jan; 31(1):e16069. PubMed ID: 37754769
[TBL] [Abstract][Full Text] [Related]
16. Late onset GM2 gangliosidosis mimicking spinal muscular atrophy.
Jamrozik Z; Lugowska A; Gołębiowski M; Królicki L; Mączewska J; Kuźma-Kozakiewicz M
Gene; 2013 Sep; 527(2):679-82. PubMed ID: 23820084
[TBL] [Abstract][Full Text] [Related]
17. Atypical presentation of late-onset Tay-Sachs disease.
Deik A; Saunders-Pullman R
Muscle Nerve; 2014 May; 49(5):768-71. PubMed ID: 24327357
[TBL] [Abstract][Full Text] [Related]
18. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease.
Seyrantepe V; Demir SA; Timur ZK; Von Gerichten J; Marsching C; Erdemli E; Oztas E; Takahashi K; Yamaguchi K; Ates N; Dönmez Demir B; Dalkara T; Erich K; Hopf C; Sandhoff R; Miyagi T
Exp Neurol; 2018 Jan; 299(Pt A):26-41. PubMed ID: 28974375
[TBL] [Abstract][Full Text] [Related]
19. A pathogenic HEXA missense variant in wild boars with Tay-Sachs disease.
Bertani V; Prioni S; Di Lecce R; Gazza F; Ragionieri L; Merialdi G; Bonilauri P; Jagannathan V; Grassi S; Cabitta L; Paoli A; Morrone A; Sonnino S; Drögemüller C; Cantoni AM
Mol Genet Metab; 2021 Jul; 133(3):297-306. PubMed ID: 34119419
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Tips from a Video Series and Literature Review of Patients with Late-Onset Tay-Sachs Disease.
Riboldi GM; Lau H
Tremor Other Hyperkinet Mov (N Y); 2022; 12():34. PubMed ID: 36618998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
